Articles
27. 10. 2015 Cancer in the older population of the Czech Republic
Population ageing has become a challenge to cancer care in developed countries. Particularities of the older population must be taken into account when considering cancer treatment. However, there is a lack of consensus on guidelines for this population due to the underrepresentation of older patients in clinical trials.
15. 1. 2014 Personalised invitations of Czech citizens to cancer screening programmes
In January 2014, a project of personalised invitations for cancer screening programmes was launched in the Czech Republic. In particular, citizens are invited to participate in colorectal cancer screening (men and women), as well as breast cancer screening and cervical cancer screening (women). Personalised invitations are aimed at citizens who have not participated in cancer screening programmes in the long term, and therefore are at a higher risk of developing cancer. The project is expected to increase participation rates in Czech cancer screening programmes.
» Archive
All projects
CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control
Based on the Czech information system of cancer care, the Czech Republic has been selected as a model country for the development of a Comprehensive Cancer Care Network (CCCN).
CAR-TOOL
The aim of the project is to collect and evaluate data from real clinical practice, which are related to the administration of CAR-T cell therapy in patients with certain hematological malignancies who face poor prognosis. CAR-T cell therapy is currently indicated in adult patients with certain types of non-Hodgkin's lymphoma, incl. aggressive, relapsing or refractory diffuse large B-cell lymphoma, primary mediastinal B-lymphoma, high-grade B-lymphoma, transformed follicular lymphoma and mantle cell lymphoma; and in pediatric patients and patients under 25 years of age with acute lymphoblastic leukemia (B-ALL) who do not respond to a defined number of standard therapy lines.
Cervix.cz – Cervical Cancer Screening Programme in the Czech Republic
System of informational support for the Cervical Cancer Screening Programme in the Czech Republic.
CyRUS – Cystectomy Registry of the Czech Urological Society
Clinical registry monitoring cases of bladder cancers treated with cystectomy and consecutive treatment.
Data and projects of the Czech Society for Oncology
The Czech Society for Oncology (CSO) is the principal authority coordinating cancer-related activities in the Czech Republic.
I-COP: Information centre for cancer care facilities
Informational and analytical platform enabling the evaluation of complex aspects of health care provided to cancer patients in particular.
Kolorektum.cz – Colorectal Cancer Screening Programme in the Czech Republic
System of informational support for the Colorectal Cancer Screening Programme in the Czech Republic.
Mamo.cz – Breast Cancer Screening Programme in the Czech Republic
System of informational support for the Breast Cancer Screening Programme in the Czech Republic.
NOP On-line
Project based on the development of a web portal containing detailed information on cancer care provided in the Czech Republic and on current nationwide projects focused on cancer prevention and cancer research.Pemetrexed
Clinical registry of pleural mesothelioma patients who have been treated with pemetrexed (Alimta®).
PET/CT-CZ(Q)
Terminated project developing a data background for the monitoring of numbers and indications of PET/CT scans in the clinical practice of Czech health care facilities.
reGISTer
Terminated clinical registry that monitored the epidemiology of gastrointestinal stromal tumours (GIST) as well as therapeutic approaches and treatment results in GIST patients in the Czech Republic and Slovakia.
Rektum.cz
The portal rektum.cz is dedicated mainly to the education of health care professionals on the issue of rectal cancer, which is diagnosed as C20 under the ICD-10 classification.
SVOD: Cancer epidemiology in the Czech Republic
Research project based on the development of a web portal about the cancer epidemiology in the Czech Republic. Its primary objective is to provide access to these valuable data to a wide spectrum of users from the Czech Republic as well as from abroad.
Tulung
Clinical registry of non-small cell lung cancer (NSCLC) patients who have been treated with bevacizumab (Avastin®), erlotinib (Tarceva®), gefitinib (Iressa®), pemetrexed (Alimta®), afatinib (Giotrif®) and/or nintedanib (Vargatef®).
Uroweb
Presentation of data and strategic importance in the Czech urology as regards the treatment of urological malignancies.